Biotechnology company focused on the development of novel therapeutics for age-related degenerative disease
AgeX is a biotechnology company focused on the development of novel therapeutics for age-related degenerative disease. AgeX’s mission is to apply the proprietary technology platform related to telomerase-mediated cell immortality and regenerative biology to address a broad range of diseases of aging. The current preclinical development efforts include two cell-based therapies derived from telomerase-positive pluripotent stem cells and two product candidates derived from the company’s proprietary induced Tissue Regeneration (iTR™) technology. AGEX-BAT1 and AGEX-VASC1 are cell-based approaches in the preclinical stage of development comprised of young regenerative cells modified using AgeX’s UniverCyte™ technology facilitating immune tolerance, formulated in HyStem® matrix, designed to correct metabolic imbalances in aging and to restore vascular support in ischemic tissues respectively. AGEX-iTR1547 is a drug-based formulation in preclinical development intended to restore regenerative potential in a wide array of aged tissues afflicted with degenerative disease using the company’s proprietary iTR technology.
March-2023: Received a $10,000,000 loan from Juvenescence to acquire Serina Therapeutics Inc. Plans to spinoff of its subsidiary Reverse Bioengineering. Michael West stepping down as CEO of AgeX but will continue as CEO of Reverse Bio.
Visit website: https://www.agexinc.com/
People at AgeX Therapeutics
AgeX Therapeutics News
AgeX credit running out with substantial doubt it can continue
FierceBiotech - 15-Aug-2022
Let's hope their research is either successful for the company or its successorsRead more...
Merger between regeneration companies AgeX and LyGenesis not going ahead
Business Wire - 23-Jul-2021
Both companies to continue with the diverse technologies and product developmentRead more...
Orion College ageing research receives 1 million UK pounds from Jim Mellon
Lifespan.io (LEAF) - 18-May-2020
He believes in the importance of boosting immunoresilience among elderlyRead more...
Stem cells from a 110-year-old women open doors to aging research
Phys.org - 20-Mar-2020
Scientists created stem cells from supercentenarian for the first time, calling it "super sauce"Read more...
Donor supercentenarian’s cells help unlock mysteries of super-longevity
Longevity Technology - 28-Feb-2020
Evidence of cellular age reversal demonstrated in this gateway researchRead more...
Fight Aging! reports back from SENS Research Foundation Pitch Day
Fight Aging! - 20-Jan-2020
When some of these succeed in human trials even more money will pile in to fund further advancesRead more...
Method of Generating Induced Pluripotent Stem Cells
Longevity Technology - 10-Dec-2019
New reprogramming technology could provide an alternate source of material needed for therapiesRead more...
LEAF interviews AgeX Therapeutics CEO Dr. Michael West
Lifespan.io (LEAF) - 30-Sep-2019
May only be a few years away from implementing induced tissue regeneration in humansRead more...
Michael West examines how to safely revive telomerase
Lifespan.io (LEAF) - 12-Sep-2019
It powers foetal development and telomere length, but also cancersRead more...
Today's 50 year-olds may live another 100 years
Forbes - 26-Aug-2019
Good summary of some major investments in life extension companiesRead more...
Aubrey de Grey shortens timeframe for human rejuvenation
Next Big Future - 28-Feb-2019
Once proven in mice, demand and funding will surgeRead more...
AgeX Identifies Genes Implicated in Regeneration and Cancer
Business Wire - 02-Jan-2018
Study that reveals genes implicated in tissue regeneration, cancer, and aging. Worked in collabo...Read more...